These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 9157298)

  • 1. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of severe forms of myasthenia gravis.
    Iani C; Caramia M; Morosetti M; Loberti M; Palmieri MG; Meloni C; Gallucci MT; Casciani CU; Bernardi G
    Funct Neurol; 1998; 13(3):231-7. PubMed ID: 9800150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of myasthenia gravis with plasmapheresis (author's transl)].
    Reuther P; Wiebecke D; Hertel G; Böske A; Mertens HG
    Dtsch Med Wochenschr; 1979 Dec; 104(51):1806-10. PubMed ID: 520174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: treatment with plasma exchange experiences over 10 years.
    Fornádi L; Horváth R; Szobor A
    Acta Med Hung; 1991; 48(3-4):137-44. PubMed ID: 1822852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
    Huo JT; Long HL; Luo X; Xu JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of alternative treatments by patients with myasthenia gravis].
    Beekman R; Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1994 Feb; 138(6):294-6. PubMed ID: 8121511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
    Suga M; Akahonai Y; Tsujisaki M; Mori M; Yoshizaki H; Matsumoto H; Yachi A
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):734-40. PubMed ID: 7183499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
    Lamartine de Assis J
    Arq Neuropsiquiatr; 1975 Mar; 33(1):33-40. PubMed ID: 1164206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2002; 2002(4):CD002275. PubMed ID: 12519572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prethymectomy plasmapheresis in myasthenia gravis.
    Yeh JH; Chen WH; Huang KM; Chiu HC
    J Clin Apher; 2005 Dec; 20(4):217-21. PubMed ID: 16035101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exchange plasmapheresis in the combined treatment of generalized myasthenia patients].
    Sazonov AM; Lipats AA; Kil'diushevskiĭ AV; Ol'shanskiĭ AIa; Guseva LL
    Sov Med; 1984; (5):51-4. PubMed ID: 6087471
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
    Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis--a comparative study.
    Sarkar BK; Sengupta P; Sarkar UN
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1007-10. PubMed ID: 18682429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.